Publicaciones en colaboración con investigadores/as de University of Lubeck (36)

2024

  1. Age-Related Differences in Takotsubo Syndrome: Results From the Multicenter GEIST Registry

    Journal of the American Heart Association, Vol. 13, Núm. 4, pp. e030623

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Food-Induced Anaphylaxis: Data From the European Anaphylaxis Registry

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 7, pp. 2069-2079.e7

  3. Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients

    Viruses, Vol. 15, Núm. 10

2022

  1. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    npj Genomic Medicine, Vol. 7, Núm. 1

  2. Long-term topical management of psoriasis: the road ahead

    Journal of Dermatological Treatment, Vol. 33, Núm. 1, pp. 111-120

  3. Quality of life and patient-perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed-dose combination Cal/BD foam: A post-hoc analysis of PSO-LONG

    Journal of the European Academy of Dermatology and Venereology, Vol. 36, Núm. 1, pp. 60-67

2021

  1. An Experimental DUAL Model of Advanced Liver Damage

    Hepatology Communications, Vol. 5, Núm. 6, pp. 1051-1068

  2. Wheat Anaphylaxis in Adults Differs from Reactions to Other Types of Food

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 7, pp. 2844-2852.e5

2020

  1. A call for a global COVID-19 Neuro Research Coalition

    The Lancet Neurology

  2. General practice recommendations for the topical treatment of psoriasis: a modified-Delphi approach

    BJGP Open, Vol. 4, Núm. 5, pp. 1-11

  3. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use

    Journal of cardiovascular pharmacology, Vol. 76, Núm. 1, pp. 4-22

  4. Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use

    Cardiac Failure Review, Vol. 6

  5. Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database

    Autoimmunity Reviews, Vol. 19, Núm. 2

  6. Risk Factors and Characteristics of Biphasic Anaphylaxis

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 8, Núm. 10, pp. 3388-3395.e6

2019

  1. An international perspective on hospitalized patients with viral community-acquired pneumonia

    European Journal of Internal Medicine, Vol. 60, pp. 54-70

  2. Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database

    Scandinavian Journal of Rheumatology, Vol. 48, Núm. 1, pp. 42-51

  3. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

  4. International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia

    Journal of Infection, Vol. 79, Núm. 4, pp. 300-311

  5. Itch relief in patients with psoriasis: effectiveness of calcipotriol plus betamethasone dipropionate foam

    Journal of the European Academy of Dermatology and Venereology, Vol. 33, Núm. 4, pp. 709-717